Diabetes and associated cardiovascular complications: The role of microRNAs

Abstract

Diabetes mellitus (DM) refers to a complex cluster of metabolic disorders characterized by hyperglycemia caused by inadequate insulin secretion, insulin resistance, or excessive glucagon secretion. If not correctly treated, the prolonged effects of DM-associated metabolic perturbations lead to systemic vascular complications and cardiovascular disease (CVD), the principal cause of mortality among patients with DM. Given the increase in the global prevalence of diabetes, novel diagnostic and therapeutic procedures are necessary for its effective identification and treatment. Recent findings point to an important role of microRNA (miRNAs) in DM initiation and progression, as well as the occurrence of associated cardiovascular complications. miRNAs are short, highly conserved, single-stranded, non-coding RNAs that contribute to the maintenance of physiological homeostasis through the regulation of crucial processes such as metabolism, cell proliferation, and apoptosis. The increased availability of high-throughput methodologies for identifying and characterizing non-coding RNAs has led to considerable interest in miRNAs as potential biomarkers and therapeutic agents for DM. In this review, we first comprehensively detail the regulatory miRNAs involved in the pathophysiology of DM and diabetic cardiomyopathy (DCMP). Subsequently, we summarize findings regarding the utility of several of these miRNAs as potential prognostic and diagnostic biomarkers for DM and DM-associated CVD. Finally, we evaluate the potential of miRNA-based therapeutic approaches for treating DM and DCMP in the clinical setting.

Decoding cardiovascular risks: analyzing type 2 diabetes mellitus and ASCVD gene expression

“…Moreover, our findings highlight the intricate regulation of LDL particle clearance, encompassing both its enhancement and the suppression of the receptor’s catabolic processes, as well as the facilitation of cholesterol transport via receptor-mediated endocytosis. This aligns with and substantiates the findings reported in existing literature ( 23 , 24 ). This suggests that lipid metabolism plays a crucial role in the process of elevated cardiovascular disease risk in people with T2DM.…”